We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Should Identify Methods to Avoid Missing Data in Trials
Sponsors Should Identify Methods to Avoid Missing Data in Trials
October 14, 2010
To avoid problems with missing data in clinical trials, sponsors should identify, before beginning a trial, methods to account for planning, conducting or analyzing results of a confirmatory study, according to a final guideline recently released by the European Medicines Agency (EMA). Includes the full text of European Medicines Agency Guideline
on Missing Data in Clinical Trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor